The Saatchi bill won’t find a cure for cancer, but it will encourage charlatans
Jump to follow-up
Maurice Nathan Saatchi, Baron Saatchi is an advertising man who, with his brother, Charles Saatchi ("‘why tell the truth when a good lie will do?), became very rich by advertising cigarettes and the Conservative party. After his second wife died of cancer he introduced a private members bill in the House of Lords in 2012. The Medical Innovation Bill came back to the Lords for its second reading on 24 October 2014.
The debate was deeply depressing: very pompous and mostly totally uninformed. You would never have guessed that the vast majority of those who understand the problem are a...
Source: DC's goodscience - October 24, 2014 Category: Science Authors: David Colquhoun Tags: business CAM cancer Cancer act Saatchi Bill alternative medicine antiscience badscience Source Type: blogs
The Saatchi bill won’t find a cure for cancer, but it will encourage charlatans
Jump to follow-up
Maurice Nathan Saatchi, Baron Saatchi is an advertising man who, with his brother, Charles Saatchi ("‘why tell the truth when a good lie will do?), became very rich by advertising cigarettes and the Conservative party. After his second wife died of cancer he introduced a private members bill in the House of Lords in 2012. The Medical Innovation Bill came back to the Lords for its second reading on 24 October 2014.
The debate was deeply depressing: very pompous and mostly totally uninformed. You would never have guessed that the vast majority of those who understand the problem are a...
Source: DC's goodscience - October 24, 2014 Category: Science Authors: David Colquhoun Tags: business CAM cancer Cancer act Saatchi Bill alternative medicine antiscience badscience Source Type: blogs
Peter Wilmshurst 's reply
Courage is a much needed commodity in medicine, and few have shown it with such persistence as Peter Wilmshurst. Always ready to speak out against wrongdoing whatever the personal cost, he endured a lengthy lawsuit after highlighting research misconduct at the company whose device he was evaluating (BMJ 2011;342:d2646, doi:10.1136/bmj.d2646; BMJ 2012;344:e2226, doi:10.1136/bmj.e2226). Last year he emerged triumphant, and Minerva is pleased to report that at the BMJ’s Christmas party he was presented with the first ever BMJEditor’s Award, “for courage and persistence in speaking truth to power...
Source: PharmaGossip - February 6, 2013 Category: Pharma Commentators Authors: insider Source Type: blogs
